Viritis

Next-generation antisense-based antiviral treatments

Health Tech & Life Sciences
Active
Pre-Seed Petah Tikva, Israel Founded 2020
Last updated 2026-06-18
Total raised
$665K
Last: Grant 2025-02
Stage
Pre-Seed
Founded
2020
Headcount
4
HQ
Petah Tikva, Israel
Sector
Health Tech & Life Sciences

About

Viritis is a biotech company pioneering a next-generation antisense-based platform for rapid development of antiviral drugs. Our novel technology targets all strains of a given virus, offering a scalable and precise solution for current and emerging viral threats. Our platform combines AI-driven algorithms with patented molecule design to bind specifically to viral RNA. Once attached, it activates the cell’s innate defense mechanisms, degrading the virus from within— without harming the host. After completing its function, the molecule naturally disintegrates within hours, leaving no harmful residues. In POC studies, our platform demonstrated 97.1% cellular protection against the target virus. Its innovative structure also makes it highly stable, can be lyophilize, and easy to store and transport—ideal for global deployment.

Funding history · 4 rounds · $665K total

2025-02
Grant $500K
2025-02
$85K
2023-03
$30K

Q&A

What is Viritis's primary focus?
Viritis is a biotech company focused on pioneering next-generation antisense-based antiviral treatments, utilizing an AI-driven platform to develop drugs that target all strains of a given virus.
When was Viritis founded?
Viritis was founded in August 2020.
What is Viritis's current funding stage?
Viritis is currently in the Pre-Seed funding stage.
What was Viritis's most recent funding round?
In February 2025, Viritis received a Grant of $500,000. In the same month, they also raised $85,000 from investor Road2.
What is the total amount of funding Viritis has raised to date?
Viritis has raised a total of $665,000 USD.
Who are the co-founders of Viritis?
The co-founders of Viritis include Aaron Wis (Chairman), Amit Turman (Co-founder & CEO), and Amit Philosoph (Chief Scientist).
Does Viritis hold any patents?
Yes, Viritis holds one patent.

Team · 3

Founder · Chairman
LinkedIn ↗
Founder · Co-founder & CEO
LinkedIn ↗
Founder · Chief Scientist
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
Artificial IntelligenceMaterials & SubstancesNanomaterialsBiologicalsCellsMolecules
Target customers
Healthcare & Life SciencesLife SciencesBiotechnologyPharmaceuticals
Business model
B2B

Highlights

1 PatentsVerified

Tags

pharmaceuticalsvaccinesoral-drugstherapeuticsdrug-deliverytreatmentsviral-diseasesbiotechnologybiopharmaceuticaldrug-designnanotechnology
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websiteviritis.org/
LinkedInlinkedin.com/company/70943980

Identifiers & details

Founded2020-8
Employees (exact)4

Radar intelligence

Patents

EPO1

Web history (Wayback)

Domainviritis.org

Certificate / subdomain footprint

Subdomains6